WORK Medical Technology Group is trading 5.16% higher at $1.94 on September 25, 2026, with no clear direct catalyst identified.

  • No company-specific announcement or filing was identified, and available news coverage does not point to a direct catalyst.
  • Healthcare shares are higher amid renewed biotech optimism, while major U.S. indexes are also advancing. These conditions may be supportive, but the available evidence does not establish a cause for the stock’s gain.